News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sentigen Holding Corp. Announces Annual And Fourth Quarter Results
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sentigen Holding Corp. (NasdaqSC: SGHL), today reported results for the year and fourth quarter ended December 31, 2003.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Earnings
AbbVie tops Q1 estimates, raises outlook and discontinues cancer candidate
April 29, 2026
·
3 min read
·
Gabrielle Masson
Earnings
With growth curve trending up, Biogen looks to early-stage assets for ‘next generation’
April 29, 2026
·
3 min read
·
Annalee Armstrong
Earnings
Regeneron basks in first gene therapy approval as Dupixent, Eylea carry robust Q1 earnings
April 29, 2026
·
3 min read
·
Heather McKenzie
Alzheimer’s disease
Biogen ready to catch Alzheimer’s patients transitioning off Lilly’s Kisunla
April 29, 2026
·
3 min read
·
Annalee Armstrong
